2-amino-7-phosphonoheptanoic acid has been researched along with Anochlesia in 6 studies
2-amino-7-phosphonoheptanoic acid: (D)-isomer active as an antagonist of N-methyl-D-aspartate excitation of central neurons; (L)-isomer inactive; RN given refers to cpd without isomeric designation
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study examined whether the catalepsy induced by L-NOARG (ip) can be influenced by collicular glutamatergic mechanisms and if a NO-dependent neural substrate into the IC plays a role in this immobility state." | 1.38 | L-NOARG-induced catalepsy can be influenced by glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus. ( Barbosa-Silva, R; Iacopucci, AP; Mello, RO; Melo-Thomas, L, 2012) |
| "Haloperidol-induced catalepsy was challenged with prior intracollicular microinjections of glutamate NMDA receptor antagonists, MK-801 (15 or 30 mmol/0." | 1.36 | Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy. ( Brandão, ML; Coimbra, NC; Ferrari, EA; Francisco, A; Maisonnette, SS; Medeiros, P; Mello, RO; Melo, LL; Santos, P, 2010) |
| "Therefore, the THC-induced catalepsy model may be useful for distinguishing between both classes of NMDA receptor antagonists." | 1.29 | Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice. ( Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I, 1994) |
| "The potentiation of methadone-induced catalepsy in decorticated rats was mimicked in naive rats by intrastriatal (i." | 1.27 | Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists. ( Consolo, S; Forloni, G; Ladinsky, H; Palazzi, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melo, LL | 1 |
| Santos, P | 1 |
| Medeiros, P | 1 |
| Mello, RO | 2 |
| Ferrari, EA | 1 |
| Brandão, ML | 1 |
| Maisonnette, SS | 1 |
| Francisco, A | 1 |
| Coimbra, NC | 1 |
| Iacopucci, AP | 1 |
| Barbosa-Silva, R | 1 |
| Melo-Thomas, L | 1 |
| Kinoshita, H | 1 |
| Hasegawa, T | 1 |
| Kameyama, T | 1 |
| Yamamoto, I | 1 |
| Nabeshima, T | 1 |
| Urbańska, E | 1 |
| Ikonomidou, C | 1 |
| Sieklucka, M | 1 |
| Turski, WA | 1 |
| Millan, MH | 1 |
| Wardley-Smith, B | 1 |
| Halsey, MJ | 1 |
| Meldrum, BS | 1 |
| Consolo, S | 1 |
| Forloni, G | 1 |
| Ladinsky, H | 1 |
| Palazzi, E | 1 |
6 other studies available for 2-amino-7-phosphonoheptanoic acid and Anochlesia
| Article | Year |
|---|---|
Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
Topics: 2-Amino-5-phosphonovalerate; Animals; Catalepsy; Dizocilpine Maleate; Dose-Response Relationship, Dr | 2010 |
L-NOARG-induced catalepsy can be influenced by glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Catalepsy; Dose-Response Relationship, Drug; Drug Administrati | 2012 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; | 1994 |
Aminooxyacetic acid produces excitotoxic lesions in the rat striatum.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Aminooxyacetic Acid; Animals; Behavior, Animal; Catalepsy; | 1991 |
Studies on the role of the NMDA receptor in the substantia nigra pars reticulata and entopeduncular nucleus in the development of the high pressure neurological syndrome in rats.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Atmospheric Pressure; Catalepsy; G | 1989 |
Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Catalepsy; Cerebral Cortex; Cere | 1988 |